MicroRNAs Are Involved in Homocysteine-Induced Cardiac Remodeling

Cell Biochemistry and Biophysics

Volumn 55, Issue 3, 2009, Pages 153-162

  Mishra, Paras K ^a   Tyagi, Neetu ^a   Kundu, Soumi ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Congestive heart failure; Dicer; Extracellular matrix remodeling; Hyperhomocysteinemia; Matrix metalloproteinase (MMP); MicroRNA; Tissue inhibitors of metalloproteinase (TIMP)

Indexed keywords

HOMOCYSTEINE; MATRIX METALLOPROTEINASE; MICRORNA; NOX4 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RIBONUCLEASE III; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; ARTICLE; CELL LINE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; HEART MUSCLE CELL; HYPERHOMOCYSTEINEMIA; METABOLISM; MOUSE; PHYSIOLOGY; REGENERATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION PROFILING; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MATRIX METALLOPROTEINASES; MICE; MICRORNAS; MYOCYTES, CARDIAC; NADPH OXIDASE; REGENERATION; RIBONUCLEASE III; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 73349118462     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-009-9063-6     Document Type: Article

References (46)

1. Herrmann, W., Herrmann, M., & Obeid, R. (2007). Hyperhomocysteinaemia: A critical review of old and new aspects. Current Drug Metabolism, 8(1), 17-31.
2. Martin-Herrero, F., Jimenez-Candil, J., Martin-Moreiras, J., Pabon, P., Cruz-Gonzalez, I., Martin-Garcia, A., et al. (2008). Homocysteine, cause or consequence? International Journal of Cardiology, 129(2), 276-277.
3. Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., et al. (2004). Facts and recommendations about total homocysteine determinations: An expert opinion. Clinical Chemistry, 50(1), 3-32.
4. Wierzbicki, A. S. (2007). Homocysteine and cardiovascular disease: A review of the evidence. Diabetes & Vascular Disease Research, 4(2), 143-150.
5. Jhee, K. H., & Kruger, W. D. (2005). The role of cystathionine beta-synthase in homocysteine metabolism. Antioxidants Redox Signaling, 7(5-6), 813-822.
6. Graham, I. M., Daly, L. E., Refsum, H. M., Robinson, K., Brattstrom, L. E., Ueland, P. M., et al. (1997). Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA, 277(22), 1775-1781.
7. Blacher, J., Demuth, K., Guerin, A. P., Vadez, C., Moatti, N., Safar, M. E., et al. (1999). Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. Journal of Nephrology, 12(4), 248-255.
8. Blacher, J., & Safar, M. E. (2001). Homocysteine, folic acid, B vitamins and cardiovascular risk. Journal of Nutrition, Health & Aging, 5(3), 196-199.
9. Lee, R. T. (2001). Matrix metalloproteinase inhibition and the prevention of heart failure. Trends in Cardiovascular Medicine, 11(5), 202-205.
10. Sakata, Y., Yamamoto, K., Mano, T., Nishikawa, N., Yoshida, J., Hori, M., et al. (2004). Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: Its inhibition as a primary effect of angiotensin-converting enzyme inhibitor. Circulation, 109(17), 2143-2149.
11. Spinale, F. G., Coker, M. L., Bond, B. R., & Zellner, J. L. (2000). Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target. Cardiovascular Research, 46(2), 225-238.
12. Tyagi, S. C., Smiley, L. M., Mujumdar, V. S., Clonts, B., & Parker, J. L. (1998). Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Molecular and Cellular Biochemistry, 181(1-2), 107-116.
13. Lominadze, D., Roberts, A. M., Tyagi, N., Moshal, K. S., & Tyagi, S. C. (2006). Homocysteine causes cerebrovascular leakage in mice. American Journal of Physiology. Heart and Circulatory Physiology, 290(3), H1206-H1213.
14. Moshal, K. S., Sen, U., Tyagi, N., Henderson, B., Steed, M., Ovechkin, A. V., et al. (2006). Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. American Journal of Physiology. Cell Physiology, 290(3), C883-C891.
15. Moshal, K. S., Tipparaju, S. M., Vacek, T. P., Kumar, M., Singh, M., Frank, I. E., et al. (2008). Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. American Journal of Physiology. Heart and Circulatory Physiology, 295(2), H890-H897.
16. Tyagi, S. C., Rodriguez, W., Patel, A. M., Roberts, A. M., Falcone, J. C., Passmore, J. C., et al. (2005). Hyperhomocysteinemic diabetic cardiomyopathy: Oxidative stress, remodeling, and endothelial-myocyte uncoupling. Journal of Cardiovascular Pharmacology and Therapeutics, 10(1), 1-10.
17. Cheng, Y., Ji, R., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? American Journal of Pathology, 170(6), 1831-1840.
18. Mishra, P. K., Tyagi, N., Kumar, M., & Tyagi, S. C. (2009). MicroRNAs as a therapeutic target for cardiovascular diseases. Journal of Cellular and Molecular Medicine, 13(4), 778-789.
19. Sayed, D., Hong, C., Chen, I. Y., Lypowy, J., & Abdellatif, M. (2007). MicroRNAs play an essential role in the development of cardiac hypertrophy. Circulation Research, 100(3), 416-424.
20. Tatsuguchi, M., Seok, H. Y., Callis, T. E., Thomson, J. M., Chen, J. F., Newman, M., et al. (2007). Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology, 42(6), 1137-1141.
21. Thum, T., Catalucci, D., & Bauersachs, J. (2008). MicroRNAs: Novel regulators in cardiac development and disease. Cardiovascular Research, 79(4), 562-570.
22. van Rooij, E., & Olson, E. N. (2007). MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. Journal of Clinical Investigation, 117(9), 2369-2376.
23. Yang, W. J., Yang, D. D., Na, S., Sandusky, G. E., Zhang, Q., & Zhao, G. (2005). Dicer is required for embryonic angiogenesis during mouse development. Journal of Biological Chemistry, 280(10), 9330-9335.
24. Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136(2), 215-233.
25. Latronico, M. V., Catalucci, D., & Condorelli, G. (2007). Emerging role of microRNAs in cardiovascular biology. Circulation Research, 101(12), 1225-1236.
26. Lai, E. C. (2002). Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nature Genetics, 30(4), 363-364.
27. Borchert, G. M., Lanier, W., & Davidson, B. L. (2006). RNA polymerase III transcribes human microRNAs. Nature Structural & Molecular Biology, 13(12), 1097-1101.
28. Zhang, C. (2008). MicroRNAs: Role in cardiovascular biology and disease. Clinical Science, 114(12), 699-706.
29. Ruby, J. G., Jan, C. H., & Bartel, D. P. (2007). Intronic microRNA precursors that bypass Drosha processing. Nature, 448(7149), 83-86.
30. Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H., & Cuppen, E. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 120(1), 21-24.
31. Zhang, C. (2008). MicroRNomics: A newly emerging approach for disease biology. Physiological Genomics, 33(2), 139-147.
32. Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., et al. (2003). Dicer is essential for mouse development. Nature Genetics, 35(3), 215-217.
33. Murchison, E. P., Stein, P., Xuan, Z., Pan, H., Zhang, M. Q., Schultz, R. M., et al. (2007). Critical roles for Dicer in the female germline. Genes and Development, 21(6), 682-693.
34. Lynn, F. C., Skewes-Cox, P., Kosaka, Y., McManus, M. T., Harfe, B. D., & German, M. S. (2007). MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes, 56(12), 2938-2945.
35. Koralov, S. B., Muljo, S. A., Galler, G. R., Krek, A., Chakraborty, T., Kanellopoulou, C., et al. (2008). Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell, 132(5), 860-874.
36. Davis, T. H., Cuellar, T. L., Koch, S. M., Barker, A. J., Harfe, B. D., McManus, M. T., et al. (2008). Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. Journal of Neuroscience, 28(17), 4322-4330.
37. Kuehbacher, A., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research, 101(1), 59-68.
38. Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129(2), 303-317.
39. Suarez, Y., Fernandez-Hernando, C., Pober, J. S., & Sessa, W. C. (2007). Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circulation Research, 100(8), 1164-1173.
40. Chen, J. F., Murchison, E. P., Tang, R., Callis, T. E., Tatsuguchi, M., Deng, Z., et al. (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Science of the United States of America, 105(6), 2111-2116.
41. de Ruijter, W., Westendorp, R. G., Assendelft, W. J., den Elzen, W. P., de Craen, A. J., le Cessie, S., et al. (2009). Use of Framingham risk score, new biomarkers to predict cardiovascular mortality in older people: Population based observational cohort study. BMJ, 338, a3083.
42. Kundu, S., Kumar, M., Sen, U., Mishra, P. K., Tyagi, N., Metreveli, N., et al. (2009). Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. Journal of Cellular Biochemistry, 106(1), 119-126.
43. Tyagi, S. C., & Hoit, B. D. (2002). Metalloproteinase in myocardial adaptation and maladaptation. Journal of Cardiovascular Pharmacology and Therapeutics, 7(4), 241-246.
44. Hsu, C. P., Huang, C. Y., Wang, J. S., Sun, P. C., & Shih, C. C. (2008). Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair. Annals of Thoracic Surgery, 86(4), 1243-1249.
45. Claycomb, W. C., Lanson, N. A., Jr., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., et al. (1998). HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proceedings of the National Academy of Science of the United States of America, 95(6), 2979-2984.
46. Tyagi, S. C. (1999). Homocysteine and heart disease: Pathophysiology of extracellular matrix. Clinical and Experimental Hypertension, 21(3), 181-198.